A & D

Quick links to important sections

A & D

Method of action: Vitamins

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of A & D

Here is a quick overview of the essential facts about the composition and nature of A & D.

Property Description
Active Ingredients Dihydrotachysterol, Vitamin A, Vitamin E
Forms Oral Drops/Solution, Capsules, Ointment
Pharmacological Class Fat-Soluble Vitamin Combination, Calcium Regulator
Common Use Nutritional support and deficiency prevention
Origin Derived (Synthetic analog + Essential Nutrients)

A & D is categorized as a combination vitamin preparation and nutritional supplement primarily used to deliver essential fat-soluble vitamins and support the body's mineral balance. It is designed to provide comprehensive support for processes related to bone health, vision, and cellular protection.

The medication is formally classified within the Pharmacological Class of Fat-Soluble Vitamin Combinations and serves as a Calcium Metabolism Regulator due to the action of one of its core components. A & D is considered a combination product because it contains multiple active ingredients intended to work together across several physiological systems.

What Type of Medicine is A & D?

A & D is categorized as a Derived product because it combines essential natural nutrients with a modified, synthetic compound. Its three main Active Ingredients are Dihydrotachysterol, Vitamin A (often as Retinol or a derivative like retinyl palmitate), and Vitamin E (alpha-Tocopherol).

Dihydrotachysterol is a synthetic analog of Vitamin D, which is used to manage calcium levels in the body. Vitamin A is crucial for maintaining vision and supporting immune function, while Vitamin E provides vital antioxidant protection against free radicals. This specific blend is often formulated in an oily base for better stability and absorption, reflecting the fat-soluble nature of all its active components.

Forms and General Purpose

A & D is typically available as an oral solution or drops for ingestion, or as a topical preparation such as an ointment or cream. The most common Routes of Administration are Oral or Topical, depending on the market formulation and intended patient group.

The general purpose of A & D is to prevent or correct deficiencies of these specific fat-soluble vitamins, which are necessary for maintaining normal function. By supporting key processes like calcium absorption and cellular defense, the supplement helps maintain the integrity of the skeletal system and supports overall tissue and visual health.

What side effects are possible with A & D?

Possible Side Effects and Safety Information

The official safety profile for A & D, derived from government regulatory documents, is structured around the differences between its localized topical use and the potential for systemic toxicity associated with chronic, excessive oral intake of its fat-soluble components.

Adverse Reactions by System-Organ Class

Adverse reactions associated with the topical preparation are primarily classified under Skin and Subcutaneous Tissue Disorders. These localized effects, which are typically assigned a Not Known frequency due to post-marketing reporting, include pruritus (itching), localized irritation, and signs of allergic contact dermatitis

.

Systemic adverse effects are generally documented as consequences of prolonged excessive use of the oral components, falling under the Metabolism and Nutrition Disorders and Nervous System Disorders categories.

Serious Safety Considerations and Constraints

The most serious adverse reactions listed in regulatory documents are consequences of toxic accumulation. These include Severe Hypercalcemia and Chronic Hypervitaminosis A. Furthermore, Pseudotumor Cerebri (Intracranial Hypertension) is documented as a severe neurological risk associated with chronic Vitamin A toxicity.

The regulatory profile specifies key safety constraints. The medicine is contraindicated in individuals with pre-existing conditions such as Hypercalcemia or documented Hypervitaminosis A. Population-specific safety notes also highlight the potential teratogenic risk associated with excessive Vitamin A intake during pregnancy and the need for close monitoring in patients with renal impairment.

This framework establishes that the highest-tier safety risks are linked to the time and duration pattern of excessive intake, rather than to routine therapeutic use.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for the A & D combination product is defined by the toxicity of its fat-soluble components, primarily resulting in Hypervitaminosis A and Hypercalcemia from the Vitamin D analog (Dihydrotachysterol). Overdose symptoms are systemic and can include nausea, vomiting, anorexia, headache, vertigo, and bone and muscle pain, alongside signs of increased thirst and urination (polyuria/polydipsia).

Required Emergency Actions

Action/Symptom Regulatory Requirement
If swallowed (Oral or Topical) Contact a Poison Control Center right away or seek immediate medical help.
General Overdose Seek immediate medical attention for serious side effects, such as confusion or severe pain.

Severe outcomes documented in regulatory sources include Irreversible Renal Insufficiency, widespread soft tissue calcification, and Intracranial Hypertension (Pseudotumor Cerebri). High doses of the Vitamin E component are also associated with an increased risk of bleeding (hemorrhage). The primary management procedure is the withdrawal of the product. No specific chemical antidote is known; treatment is supportive and symptomatic, often involving procedures like vigorous hydration to manage hypercalcemia. Regular monitoring of blood calcium levels is required.

Therapeutic Uses of A & D

What A & D Treats: Main Uses and Benefits

The primary purpose of A & D ointment is to provide symptomatic relief and protective support across common skin discomforts. It is applied in contexts where short-term symptomatic assistance is needed to help support comfort.

The preparation is commonly used across therapeutic domains where additional management of discomfort is required, addressing symptoms related to diaper rash, chapped skin, minor cuts, scrapes, and burns. It helps address symptom clusters related to moisture and friction, such as the redness and irritation associated with diaper rash and chafing.

Supportive Care and Symptom Easing

The ointment is applied when symptoms create noticeable physiological strain, and provides support that helps ease the overall symptom burden of these irritative states. It is also relevant for managing symptoms of dry, cracked skin that may become more noticeable due to weather exposure. The product may assist with providing supportive relief when symptoms interfere with routine activities, such as for minor skin trauma.


Quick Fact: Relief for Dryness and Irritation This ointment is commonly used across conditions presenting with acute episodes of skin irritation or dryness, offering symptomatic relief that supports patients during episodes of heightened discomfort.


Regulatory References

  1. U.S. National Library of Medicine DailyMed Overview

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use A & D — Official Regulatory Information

The eligibility and non-eligibility for A & D are defined by government regulatory documents, specifically for its metabolic component, Dihydrotachysterol, and its topical ointment form.

Contraindications and Non-Eligibility

Category Non-Eligibility Status
Metabolic Contraindications Use is contraindicated in patients with pre-existing Hypercalcemia or Hypervitaminosis D, and in those with an abnormal sensitivity to the toxic effects of Vitamin D.
Topical Use Exclusions The ointment is not eligible for application on deep or puncture wounds, animal bites, or serious burns.

Restricted and Conditional Use

  • Organ Function: Use is restricted and requires close monitoring in patients with renal impairment or a history of renal stones. Those with Hyperphosphatemia require concurrent dietary restrictions.
  • Reproductive Status: The metabolic component is Pregnancy Category C. Use during pregnancy is conditional upon the potential benefit justifying the risk to the fetus. If used during lactation, infant serum calcium monitoring is required due to excretion into breast milk.
  • Pediatric Patients: The Vitamin D component is restricted in infants with Idiopathic Hypercalcemia. For conditions like Rickets, use is limited by a narrow therapeutic range, requiring careful determination of blood calcium levels.

What should I know about interactions with other medicines?

The interaction profile of A & D is structured around pharmacodynamic overlap and absorption interference, specifically relating to its fat-soluble components and the action of Dihydrotachysterol. Co-administration is formally restricted or contraindicated with several classes of medicines due to documented risk amplification.

Official Interaction Statements

  • Contraindicated Combinations: Combining A & D with other Retinoids or Tetracycline-class antibiotics is restricted due to the additive risk of hypervitaminosis A or pseudotumor cerebri. Other Vitamin D analogs are also contraindicated to prevent severe hypercalcemia.

  • Pharmacodynamic Risks: The product creates an additive hypercalcemic risk when co-administered with Thiazide Diuretics or Calcium Salts. Use with Cardiac Glycosides (e.g., Digoxin) is classified as a severe risk, as hypercalcemia can formally potentiate their effects, increasing the documented risk of cardiac arrhythmias. High doses of Vitamin E may potentiate the effect of Warfarin and coumarin anticoagulants, increasing the documented risk of bleeding.

  • Exposure and Timing: Bile Acid Sequestrants and Mineral Oil formally reduce the exposure of the fat-soluble vitamins by interfering with intestinal absorption. Regulatory labeling mandates that these agents be administered with a separation of several hours from A & D. Official documents note that interaction risks are heightened in patients with Renal Impairment due to their increased susceptibility to hypercalcemia.

Mechanism of Action

The molecular activity begins when the molecule enters the cell and binds to the Nuclear Receptor (NR) family. Specifically, Vitamin A derivatives bind to the Retinoic Acid Receptor (RAR) and Retinoid X Receptor (RXR), and Vitamin D metabolites bind to the Vitamin D Receptor (VDR). This binding forms a receptor-ligand heterodimer that couples with a Response Element (RE) sequence on the DNA. The subsequent recruitment of co-activator proteins drives the transcription of specific genes, which modulates expression of proteins involved in cellular differentiation and epithelial structure. Gene transcription modulated by the VDR includes proteins responsible for promoting calcium and phosphate absorption in the small intestine. This influences the genomic regulation of osteoblast and osteoclast activity and is involved in regulating calcium homeostasis. The RAR/RXR pathway also modulates gene expression relevant to rhodopsin synthesis and visual cycle function.

Dosage and Administration Information

How to Use A & D: Official Administration Guidelines

Official instructions for A & D define two distinct usage protocols based on the product’s formulation: Topical (ointment/cream) for external skin protectant use and Oral (tablets/solution) for the systemic administration of Dihydrotachysterol, a calcium regulator component.


Administration Scope

Instruction Details
Route of administration Topical or Oral.
Dosing schedule Topical: Apply liberally; dose is event-driven. Oral (Initial): Dihydrotachysterol 0.8 mg to 2.4 mg per day. Oral (Maintenance): Dihydrotachysterol 0.2 mg to 1.0 mg per day.
Frequency and Timing Topical: Applied as often as necessary, such as with each diaper change. Oral: Administered once daily (q.d.).
Preparation requirements Topical: The application area must be cleansed and allowed to dry before use. Oral: Dosing may require simultaneous administration of oral calcium supplementation.
Age-group administration rules Oral (Pediatric): Specific regimens exist for infants and children, with initial daily doses ranging from 1 mg to 5 mg followed by maintenance doses of 0.5 mg to 1.5 mg.
Special procedural conditions Topical: For external use only. Oral: Requires the dose to be individualized and subsequently adjusted based on regular determination of blood calcium levels.

Connection to the Official Protocol

The dual administration protocol establishes that the application method, frequency, and preparatory conditions are dictated by the medicine's form. The topical use is a high-frequency, as-needed routine, while the oral systemic regimen is structured as a monitored, individualized titration. This requires a stable once-daily schedule that proceeds from an initial phase to a chronic maintenance phase, conditional upon laboratory monitoring and co-administration of oral calcium.

Recent Clinical Evidence

Research evidence / Overview of studies for A & D


Research for Topical Uses: Skin Support and Minor Irritations

Research exploring the topical ointment formulation of A & D has been conducted in contexts relevant in trials assessing short-term or episodic symptom patterns, such as the management of minor skin irritation and dryness. Studies have been conducted using non-randomized prospective designs, as well as trials that measured skin barrier function. These studies observed patient-reported outcomes describing perceived discomfort related to physical discomfort like redness and chapping.

What the research describes is patterns related to changes measured during the study period, such as measurements of skin hydration and changes in symptom scores. Findings generally focus on functional data associated with the ingredients' established role in skin protection. What remains uncertain is that the evidence quality varies across studies, and there is a limited number of recent, large-scale Randomized Controlled Trials (RCTs) specifically comparing this combined ointment against current standard therapies.


Research for Oral Use: Supporting Mineral Balance

For the oral formulation, robust research has been conducted for one of its components, Dihydrotachysterol, which was studied for conditions involving chronic systemic or functional imbalance, such as hypoparathyroidism. This evidence base includes Randomized Controlled Trials (RCTs) and long-term observational cohort studies. Researchers examined how symptoms evolved in the observed populations, with a focus on Biomarkers of Calcium Homeostasis such as serum calcium and phosphorus concentrations. The studies monitored the need for ongoing laboratory assessment; findings in some studies showed patterns related to elevated calcium levels.


Research for Oral Use: Preventing Nutritional Deficiencies

Research has explored the oral combination’s role in preventing nutritional deficiencies of the three specific fat-soluble vitamins (A, D, and E) in populations at risk. Studies report how nutrient status evolved in the observed populations, and research provides insight into short-term changes in biomarker levels following oral supplementation. Foundational scientific research consistently describes the role of these three vitamins in supporting normal body functions. However, there is a lack of large-scale RCTs dedicated to comparing this exact three-part combination against individual vitamin supplementation or other combination formats.


Research Gaps and Areas of Uncertainty

The available research provides context but not individual predictions regarding whether a patient will respond similarly to the patterns observed in the studies. For the topical ointment, comparative evidence is lacking against other skin protectants in recent trials. For the oral formulation, while research has extensively studied mineral balance, the role of the combined three-vitamin formulation compared to single supplements is not completely defined. Evidence quality varies across studies, and long-term effects are not fully established for all uses.

Key Studies & References

  1. Vitamin A & Vitamin D Ointment - DailyMed (OTC monograph final)
  2. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults
  3. Vitamin E - MedlinePlus Medical Encyclopedia

Frequently Asked Questions (FAQ)

Common questions about A & D (FAQ)


Q: Is it possible to be allergic to A & D components?

Regulatory documents describe that use is contraindicated (not recommended) for individuals who have a known hypersensitivity to any component of the product. Furthermore, the official safety profile for the topical ointment includes signs of allergic contact dermatitis (a type of skin reaction) as a possible adverse effect.


Q: Is A & D safe to use on sensitive skin areas?

Official information includes localized irritation and pruritus (itching) among the possible localized effects, which may occur on sensitive areas. However, official labeling does not specifically define or address general use on sensitive skin. If discomfort is experienced, regulatory principles suggest discontinuing use and seeking guidance from a healthcare professional.


Q: What are the most commonly reported minor side effects of A & D?

For the topical preparation, official safety information lists localized effects such as pruritus (itching), localized irritation, and signs of allergic contact dermatitis. Due to the reliance on post-marketing surveillance, the frequency of these effects is often classified in regulatory documents as 'Not Known.'


Q: Is there a known maximum period for continuous use of A & D?

Official regulatory documents do not specify a formal maximum duration for routine topical use. However, the official safety profile indicates that the most serious risks for the oral components, such as Severe Hypercalcemia and Chronic Hypervitaminosis A, have been observed in contexts of prolonged excessive use.


Q: Can A & D be used on the face or near the eyes?

Official regulatory warnings for the topical product specifically mandate: 'When using this product do not get into eyes.' The product is intended for external skin use, and official warnings advise keeping the ointment away from the eye area.


Q: Is A & D the same as just a plain vitamin A ointment?

Official composition descriptions for A & D Ointment indicate it is a combination product. It contains vitamins A and D derived from Cod Liver Oil, and also lists Lanolin and Petrolatum (a form of petroleum jelly) as its primary active skin protectant ingredients. A plain Vitamin A ointment may contain only a retinoid or vitamin A derivative.


Q: What is the main difference between A & D Ointment and petroleum jelly?

The key difference is composition. Official regulatory information indicates that A & D Ointment formulations are combination products that contain Petrolatum (which is petroleum jelly) along with additional ingredients, such as Lanolin and Cod Liver Oil (containing vitamins A and D). Petroleum jelly (Petrolatum) is often a single-ingredient skin protectant.


Q: Can A & D be used for something other than its listed main purpose?

Official labeling explicitly defines the intended Uses of the topical product, which include treating and preventing diaper rash, and protecting chafed, chapped, or cracked skin. Use outside of these specified purposes is not addressed in the product information.


Q: What are the inactive ingredients found in A & D?

Official product labeling lists several inactive ingredients. These typically include Fragrance, Light Mineral Oil, Microcrystalline Wax, and Paraffin. Some formulations also contain Cod Liver Oil, which supplies the fat-soluble vitamins.


Q: Has A & D been studied in children or infants for its primary uses?

Yes. The official directions for the topical product specifically include administration instructions related to diaper changes in infants and children. Research evidence is also cited for the oral components, including pediatric regimens and safety constraints for infants with specific conditions.


Q: What kind of research evidence supports the use of A & D?

Research evidence includes studies of the topical ointment in contexts of short-term skin irritation and dryness, measuring things like skin barrier function. For the oral formulation, there are clinical trials for the component Dihydrotachysterol related to managing chronic conditions involving mineral balance, such as hypoparathyroidism.


Q: Can A & D be used by people with certain skin conditions?

The official eligibility information specifies that the ointment is not eligible for application on deep or puncture wounds, animal bites, or serious burns. Use for other specific skin conditions is not specified in the labeling, and you should seek advice from a healthcare professional for these concerns.


Q: Does A & D expire, and does it lose effectiveness?

Official documents define strict storage conditions and mandate that the product be kept in its original, tightly closed packaging. These requirements are defined to support product stability and integrity throughout its defined shelf life, which is established by the manufacturer.


Q: Is there a different formulation of A & D (like a cream or lotion)?

Yes, regulatory documents describe the product as being available in multiple forms, depending on the specific market and intended use. These forms typically include Oral Drops/Solution, Capsules, and various Topical preparations such as an Ointment or a cream formulation.


Q: Does A & D contain lanolin, and is that a common allergen?

Official labeling for A & D Ointment confirms that Lanolin is one of its active ingredients and skin protectants. Official documents contraindicate (advise against) use in individuals with known hypersensitivity to any component.


Q: Why is A & D often found in the baby care section of stores?

The main reason relates to the official regulatory Uses for the topical ointment. These uses include helping to treat and prevent diaper rash and protecting chafed skin due to diaper rash, which are common applications in infant care.


Q: Can A & D be used as a moisturizer for general dry skin?

Official documents state the product is used to 'temporarily protect and helps relieve chapped, chafed or cracked skin and lips.' These are common symptoms of dry skin, and the ingredients are classed as skin protectants.


Q: Is the vitamin D in A & D absorbed through the skin?

The official mechanism of action focuses on the local function of the topical ointment as a skin protectant (barrier). The systemic effects of Vitamin D, which regulates calcium homeostasis, are described in regulatory documents in relation to the oral component (Dihydrotachysterol).


Q: How should A & D look and smell if it's still good to use?

Official documents describe the product's typical characteristics and list ingredients like Cod Liver Oil, which has a distinct scent. While regulatory documents specify storage, they do not provide explicit guidance on what visual or odor changes signal product degradation.


Q: Why is this combination of Vitamin A and D used together?

A & D is formally classified as a combination vitamin preparation. It is designed to deliver essential fat-soluble vitamins (A, D, and E in some oral forms) to support multiple body processes, including vision, cellular protection, and the regulation of mineral balance.


Q: What are the differences between A & D Ointment and similar zinc-based products?

The difference lies in the active ingredients. The primary active ingredients and skin protectants in A & D Ointment are Lanolin and Petrolatum. Similar products described as zinc-based use Zinc Oxide as their active skin protectant ingredient instead.


Q: Is A & D a petroleum-free product?

Official regulatory documents indicate that the A & D Ointment formulation is not petroleum-free, as Petrolatum (a form of petroleum jelly) is explicitly listed as one of the active ingredients and skin protectants.


Q: Does A & D contain preservatives or parabens?

Official inactive ingredient lists vary by specific formulation (ointment vs. drops). Some versions may list substances such as Phenoxyethanol (a preservative), and the full inactive ingredient list should be reviewed on the product’s drug facts label.


Q: Can adults use A & D, or is it mainly for babies?

Adults can use the topical ointment. The official uses of the product include temporarily protecting and helping to relieve chapped, chafed, or cracked skin and lips, which applies to people of all ages.


Q: If I use A & D, do I still need to use a separate skin barrier product?

No, A & D Ointment is itself classified as a skin protectant in official labeling. Its active ingredients, Lanolin and Petrolatum, are designed to form a protective barrier on the skin.


Q: How is the quality of the ingredients in A & D regulated?

As an authorized Over-the-Counter (OTC) Human Drug, the product is subject to the rigorous quality standards and Good Manufacturing Practices (GMP) defined and enforced by the applicable government drug authority, such as the FDA.


Q: Why do some sources refer to A & D as a skin protectant?

Sources use this term because the official drug facts panel explicitly lists the Purpose of the active ingredients, Lanolin and Petrolatum, as being a Skin Protectant.


Q: Does A & D help with minor skin irritations?

Official Uses include helping to protect and relieve chapped, chafed, or cracked skin and lips, and temporarily protecting minor cuts, scrapes, and burns. These applications cover various forms of minor skin irritations.


Q: Is it true that the 'D' in A & D is cholecalciferol?

The 'D' in A & D is often associated with Vitamin D. In the topical ointment, this Vitamin D is delivered through Cod Liver Oil. For the oral formulation, the official label specifies the Vitamin D component is the synthetic analog Dihydrotachysterol, not Cholecalciferol (Vitamin D3). This distinction varies by product form.


Q: Does using A & D replace the need for regular bathing or cleaning?

The official directions for use in contexts like diaper rash specify that the application area should be cleansed and allowed to dry before the ointment is applied. This suggests that good hygiene remains a necessary preparatory step.


Q: Is A & D considered a vegan product?

A & D Ointment is not considered a vegan product. Official inactive ingredient lists include substances derived from animals, such as Lanolin (derived from sheep wool) and Cod Liver Oil (derived from fish).


Q: What are the typical packaging sizes that A & D is sold in?

Official packaging information listed by regulatory databases (such as NDC Codes) indicates that the product is sold in various sizes for tubes and jars. These commonly include small tubes (e.g., 56 g) and large jars (e.g., 454 g) to accommodate different uses.

How should A & D be stored and disposed of?

How to Store and Dispose of A & D?

The storage and handling of A & D preparations are strictly defined by regulatory documents to maintain product stability and integrity.

Storage Conditions

The product must be stored at Controlled Room Temperature (mathbf20 mathrmC to mathbf25 mathrmC), with permitted brief excursions. It is mandatory to keep the container tightly closed and store it in the original packaging.

Constraint Requirement
Temperature Do not freeze; avoid excessive heat.
Container Keep tightly closed in original packaging.
Safety Keep out of the sight and reach of children.

Disposal Instructions

Unused or expired A & D product must be disposed of according to local regulations for pharmaceutical waste. Unless advised otherwise, the product should not be flushed down the toilet or drain. If no take-back program is available, the product should be mixed with an undesirable substance and placed in a sealed bag before being discarded with household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of A & D found in:

A-Z Index: